Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

(1992): Bodokh I+, Presse Med (French) 21, 630 (1991): Hertzberger-ten-Cate R+, Clin Exp Rheumatol 9, 85 (1990): Donovan S+, Br J Rheumatol 29, 201 (4.1%) (1990): Gupta AK+, Arch Dermatol 126, 487 (23%) (1990): Petterson T+, Br J Rheumatol 29, 239 (1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223 (1989): Gremse DA+, J Pediatr Gastroenterol Nutr 9, 261 (1988): Williams HJ+, Arthritis Rheum 31, 702 (7%) (1986): Farr M+, Drugs 32 (Suppl 1), 49 (1986): Poland GA+, Am J Med 81, 707 (1985): Maayan S+, Arch Intern Med 145, 1607 (1984): Iwatsuki K+, Arch Dermatol 120, 964 (1984): Peppercorn MA, AnnInternMed101, 377 (1984): Purdy BH+, AnnInternMed100, 512 (1982): Goetz MB+, JAMA 247, 3118 (1980): Fennell RS+, Clin Pediatr 19, 124 Exfoliative dermatitis (1990): Donovan S+, Br J Rheumatol 29, 201 (1984): Sala F+, Cronica Dermatol (Italian) 15, 209 Fixed eruption (1996): Kawada A+, Contact Dermatitis 34, 155 (1988): Bharija SC+, Dermatologica 176, 108 (1987): Hughes BR+, Br J Dermatol 116, 241 (1987): Kanwar AJ+, Dermatologica 174, 104 (1986): Kanwar AJ+, Dermatologica 172, 230 (1982): Gibson JR, BMJ 284, 1529 (1980): Talbot MD, Practitioner 224, 823 Lichen planus (1995): Kaplan S+, J Rheumatol 22, 191 (1991): Alstead EM+, J Clin Gastroenterol 13, 335 Lupus erythematosus (2002): Angelova I+, World Congress Dermatol Poster, 0083 (patient has psoriasis) (2002): Siddiqui MA+, Am J Ther 9(2), 163 (passim) (2002): Tsai WC+, Clin Rheumatol 21(4), 339 (2000): Chebli JM+, Arq Gastroenterol 37(4), 224 (2000): Gunnarsson I+, Rheumatology (Oxford) 39(8), 886 (1997): Gunnarsson I+, Br J Rheumatol 36, 1089 (1996): Khattak FH+, Br J Rheumatol 35, 104 (1995): Veale DJ+, Br J Rheumatol 34, 383 (1994): Borg AA+, Clin Rheumatol 13, 522 (1994): Bray VJ+, J Rheumatol 21, 2157 (1994): Caulier M+, J Rheumatol 21, 750 (1994): Fritzler MJ, Lupus 3, 455 (1994): Mongey AB+, Br J Rheumatol 33, 789 (1994): Walker EM+, Br J Rheumatol 33, 175 (1993): Siam AR+, J Rheumatol 20, 207 (1993): Wildhagen K+, Clin Rheumatol 12, 265 (1992): Skaer TL, Clin Ther 14, 496 (1991): Alarcon-Segovia D+, Baillieres Clin Rheumatol 5, 1 (1989): Deboever G+, Am J Gastroenterol 84, 85 (1989): Sugimoto M+, Nippon Naika Gakkai Zasshi (Japanese) 78, 583 (1988): Clementz GL+, Am J Med 84, 535 (1987): Hobbs RN+, Ann Rheum Dis 46, 408 (1985): Lovisetto P+, Recenti Prog Med (Italian) 76, 110 (1985): Stratton MA, Clin Pharm 4, 657 (1983): Vanheule BA+, Eur J Pediatr 140, 66 (1982): Carr-Locke DL, Am J Gastroenterol 77, 614 (1980): Crisp AJ+, JRSocMed73, 60 (1980): Rouleau L+, Union Med Can (French) 109, 1326 Necrosis (1988): Krakamp B+, Med Klin (German) 83, 611 Photosensitivity (10%) (2006): Duparc A+, Presse Med 35(7–8), 1138 (1999): Bouyssou-Gauthier ML, Dermatology 198, 388 (1994): Shelley WB+, Cutis 53, 240 (observation) (1986): Amos RS+, BMJ 293, 420 (1–5%) (1986): Chandler MJ, JInfectDis153, 1001 Pigmentation SULFASALAZINE 513 (1992): Gabazza EC+, Am J Gastroenterol 87, 1654 (orangeyellow) Pruritus (10%) (1993): Gran JT+, Scand J Rheumatol 22, 229 (1990): Donovan S+, Br J Rheumatol 29, 201 (1990): Peppercorn MA, AnnInternMed112, 50 (1–5%) (1987): Colebunders R+, AnnInternMed107, 599 (1986): Farr M+, Drugs 32 (Suppl 1), 49 (1986): Sher MR, J Allergy Clin Immunol 77, 133 (1984): Kramer BS+, Cancer 53, 329 Pruritus ani et vulvae (1981): Modern Medicine 49, 111 Psoriasis (1991): Bliddal H+, Clin Rheumatol 10, 178 Purpura (1989): Gremse DA+, J Pediatr Gastroenterol Nutr 9, 261 Pustules (1994): Gallais V+, Ann Dermatol Venereol (French) 121, 11 Rash (sic) (>10%) (2003): Fischetti F+, Minerva Med 94(6), 437 (2000): Jung JH+, Clin Exp Rheumatol 18, 245 (1999): Besnard M+, Arch Pediatr 6, 643 (1994): McCarthy C+, Ir J Med Sci 163, 238 (1993): Koski JM, Clin Exp Dermatol 11, 169 (1992): Brooks H+, Clin Rheumatol 11, 566 (1992): Giaffer MH+, Aliment Pharmacol Ther 6, 51 (10 cases) ) (1989): Gyssens IC+, Ned Tijdschr Geneeskd (Dutch) 133, 1608 (1989): Scott DL+, J Rheumatol Suppl 16, 17 (1986): Bax DE+, Ann Rheum Dis 45, 139 (1984): Farr M+, Clin Rheumatol 3, 473 (1984): Purdy BH+, AnnInternMed100, 512 Raynaud’s phenomenon (1984): Ahmad J+, J Assoc Physicians India 32(4), 370 (1984): Peppercorn MA, AnnInternMed101, 377 (1980): Reid J+, Postgraduate Med J 56, 106 Side effects (sic) (5%) (1986): Amos RS+, BMJ 293, 420 (5.5%) Stevens–Johnson syndrome (

514 SULFASALAZINE (1981): J Antimicrob Chemother 7, 179 Cheilitis (1986): Farr M+, Drugs 32 (Suppl 1), 49 Glossitis Mucocutaneous reactions (6%) (1990): Donovan S+, Br J Rheumatol 29, 201 (6.3%) (1986): Farr M+, Drugs 32 (Suppl 1), 49 (5.5%) Oral mucosal eruption (

514 SULFASALAZINE<br />

(1981): J Antimicrob Chemother 7, 179<br />

Cheilitis<br />

(1986): Farr M+, <strong>Drug</strong>s 32 (Suppl 1), 49<br />

Glossitis<br />

Mucocutaneous reactions (6%)<br />

(1990): Donovan S+, Br J Rheumatol 29, 201 (6.3%)<br />

(1986): Farr M+, <strong>Drug</strong>s 32 (Suppl 1), 49 (5.5%)<br />

Oral mucosal eruption (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!